Table 1. Tumorigenicity of 32D cells... | American Society of Hematology

Table 1.

Tumorigenicity of 32D cells expressing distinct Bcr-Abl proteins

Bcr-Abl Form	Incidence^*	Latency^† (d)	Tumor Mass^‡ (g)
32D/vector	0/4	21	NA
32D/p230	4/4	21	1.3 ± 0.3
32D/p210	4/4	21	3.4 ± 0.3
32D/p185	4/4	21	1.5 ± 0.9

Bcr-Abl Form	Incidence^*	Latency^† (d)	Tumor Mass^‡ (g)
32D/vector	0/4	21	NA
32D/p230	4/4	21	1.3 ± 0.3
32D/p210	4/4	21	3.4 ± 0.3
32D/p185	4/4	21	1.5 ± 0.9

Number of mice with tumors/total number of mice injected.

Time in days when tumors were first observed.

Mean mass of tumors ± 1 SD.